Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Ther Drug Monit. 2023 Jan 13;45(4):539–545. doi: 10.1097/FTD.0000000000001052

Table 3.

Single- and two-time point-limited sampling models to estimate fexofenadine exposure

Timepoint(s) to
estimate AUC
R2 %MPE %MAE %RMSE
1-h 0.08 9% 27% 37%
2-h 0.23 18% 26% 35%
4-h 0.73 −2% 15% 20%
5-h 0.72 −8% 16% 21%
8-h 0.60 9% 18% 26%
1 plus 8 h 0.80 10% 13% 19%
2 plus 4 h 0.72 0.05% 15% 20%
2 plus 5 h 0.78 −2% 13% 18%
2 plus 8 h 0.81 21% 14% 21%
4 plus 8 h 0.77 −1% 13% 18%
Acceptable criteria ≥ 0.9 −5% to +5% ≤ 10% ≤ 15%

Abbreviations: AUC, area under the plasma concentration versus time curve; R2, Coefficient of Determination; %MAE, relative percent mean absolute error; %MPE, relative percent mean prediction error; %RMSE, relative percent root mean squared error.

Bold values denote that the model is within acceptable limits.